2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland.
2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland; University of Physical Education, Department of Clinical Rehabilitation, Krakow, Poland.
Adv Med Sci. 2020 Mar;65(1):197-201. doi: 10.1016/j.advms.2020.01.004. Epub 2020 Jan 31.
We sought to investigate gender-related differences in clinical outcomes after peripheral vascular interventions (PVIs) from retrograde access in patients with chronic total occlusions (CTOs) of the infrainguinal arteries.
A total of 939 consecutive patients undergoing PVI were enrolled in the study. Patients with peripheral artery diseases (PAD) and CTOs were treated with PVI from retrograde access according to the local protocol. The participants were divided according to gender. Retrograde access included distal puncturing to reach the CTO. The mean follow-up lasted 1,144.9 ± 664.3 days. Baseline characteristics, procedural and long-term outcomes were compared according to gender.
Women represented 37.4% of the study population, and more frequently suffered from hypertension (92% vs. 86%, p = 0.001) and diabetes (54% vs. 46%, p = 0.02). Males more often presented with chronic obstructive pulmonary disease (14.8% vs. 6.8%, p = 0.0003), coronary artery disease (45.4% vs. 32.7%, p = 0.0001), smoking (60.4% vs. 45%, p = 0.007) and prior PVI (25% vs. 17%, p = 0.005). The Kaplan-Meier survival curves at 5 years did not reveal gender-related differences in mortality (p = 0.8), whereas men were at a significantly higher risk of re-PVI during the follow-up period (p = 0.047). Male gender was an independent predictor of re-PVI (Hazard ratio: 1.276; 95% confidence interval: 1.015-1.614, p = 0.03).
Males are at increased risk of re-PVI compared to females with PAD and CTOs of infrainguinal arteries treated with PVI from retrograde access.
我们旨在探讨经逆行入路外周血管介入(PVI)治疗下肢慢性完全闭塞(CTO)患者的临床结局是否存在性别差异。
共纳入 939 例连续接受 PVI 的患者。根据当地方案,对患有外周动脉疾病(PAD)和 CTO 的患者进行经逆行入路 PVI 治疗。根据性别对患者进行分组。逆行入路包括远端穿刺以到达 CTO。平均随访时间为 1144.9±664.3 天。根据性别比较基线特征、手术和长期结局。
女性占研究人群的 37.4%,更常患有高血压(92% vs. 86%,p=0.001)和糖尿病(54% vs. 46%,p=0.02)。男性更常患有慢性阻塞性肺疾病(14.8% vs. 6.8%,p=0.0003)、冠心病(45.4% vs. 32.7%,p=0.0001)、吸烟(60.4% vs. 45%,p=0.007)和既往 PVI(25% vs. 17%,p=0.005)。5 年时的 Kaplan-Meier 生存曲线未显示性别与死亡率之间存在相关性(p=0.8),但男性在随访期间再次 PVI 的风险显著更高(p=0.047)。男性是再次 PVI 的独立预测因素(风险比:1.276;95%置信区间:1.015-1.614,p=0.03)。
与经逆行入路 PVI 治疗下肢 CTO 的女性 PAD 患者相比,男性再次 PVI 的风险更高。